Načítá se...
Molecular mechanism of the synergistic activity of ethambutol and isoniazid against Mycobacterium tuberculosis
Isoniazid (INH) and ethambutol (EMB) are two major first-line drugs for managing tuberculosis (TB), caused by the microbe Mycobacterium tuberculosis. Although co-use of these two drugs is common in clinical practice, the mechanism for the potential synergistic interplay between them remains unclear....
Uloženo v:
| Vydáno v: | J Biol Chem |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Biochemistry and Molecular Biology
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6204910/ https://ncbi.nlm.nih.gov/pubmed/30185616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.RA118.002693 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|